Continuous Manufacturing Market Overview

The global continuous manufacturing market is estimated to be worth over USD 972.7 Mn in 2033 and is expected to grow at CAGR of 8.5% during the forecast period (2024-2033). Continuous manufacturing is a disruptive approachto manufacturing that replaces the conventional batch processing with a smooth, progressive flow of materials through the manufacturing process. Contrary to the traditional techniques that entailstarting and stopping at different stages, continuous manufacturing enables for a continuous stream of raw materials to be transfigured into finished products without cessation. Owing to which, the production process becomes more efficient, mitigate extra time consumption and overall improves product quality.

Over the years, progresses and breakthroughs in manufacturing technologies have encouraged pharmaceutical firms to switch from the conventional multiple-step, batch manufacturing processes to quicker and comparatively efficient continuous manufacturing.The idea was initiallyportrayed in the 1700s, for the manufacturing of pig iron in blast furnaces. Ever since, the approach has been adopted by numerous industries, including chemicals, food and beverage, automotive, oil refining, electronics, pulp and paper, steel making, metal smelting, and waste-water treatment industries. In the past few years, continuous manufacturing has gained momentum in the biopharmaceutical industry as well, having seized the attention of big pharma players, as well as key contract manufacturing organizations (CMOs).

Continuous manufacturing enables a more rationalized and pliantmanufacturing of pharmaceuticals, paving its way tofaster time-to-market for novel drugs and enhancedall in all productivity. The focus on quality control and regulatory conformity is also amplified with continuous manufacturing, as the uninterrupted nature of the process enables for real-time monitoring and adjustments.

The market for continuous manufacturing is not restricted to a particular industry; it expands to electronics, chemicals, and other manufacturing spheres. Since technology persists to progress, several industries are acknowledging the prospectiveadvantages of this groundbreaking approach. Companies are investing in research and development to improve the adaptability and scalability of continuous manufacturing systems, making sure they meet the specializedneeds of various sectors.

Thus, the novel concept of continuous manufacturing portrays a dramatic shift in manufacturingtechniques, deliveringescalated efficiency, mitigated waste, and improved product quality. The market for continuous manufacturing is experiencingvigorous growth as industries address the revolutionary potential of this approach, making it a central point for invention and investment across varied sectors.

Figure 1. Continuous Manufacturing: Market Size

Get more details on this report - Request Free Sample

Key Market Insights

The global continuous manufacturing market is undergoing a noteworthyupturn, caused by a convergence of factors definingcontemporary manufacturing practices. With a growing focus on efficacy and sustainability, industries across food and beverages, pharmaceuticals, electronics, and chemicalsare swiftly adopting continuous manufacturing systems. This movement is highlighted by the significantdecline in manufacturing time, mitigated waste, and escalated quality control accommodated by continuous manufacturing approaches.

Pharmaceuticals go to great lengths in the adoption of continuous manufacturing, leveraging its benefits to facilitate drug development and improvethe whole productivity. Since the industry endures to prioritize time-to-market and regulatory compliance, continuous manufacturing sticks out as a catalyst for achieving these goals. In addition to that, the food and beverage sphereareperceiving a soar in the adoption of continuous manufacturing, allowingspry and various production capacities.

The market's growth course is further accelerated by continuing research and development schemes, geared towardsprocessing the adaptability and scalability of continuous manufacturing systems. This technology-driven evolution ensures that various industries can exploit the advantages of continuous manufacturing, locating it as a crucial element in the innovation of global manufacturing practices. As industries more and moreidentify the life-changingprospective of continuous manufacturing, investments in innovation and infrastructure are accelerating this market to new frontiers.

Current Market Landscape:

In the past few years, the notion of continuous manufacturing has picked up steam across numerous industries around the world including the biopharmaceutical industry. The novel concept has positively drew the attention of huge pharma players, as well as key contract manufacturing organizations (CMOs).As a matter of fact, more than 20 biologics manufactured employing this method have been approved by the FDA. Along with that, the continuous processing technology exhibits a multifaceted and favourable manufacturing approach for oral solid dosage (OSD) forms and small molecules as well. In recent years, several orally administrable drugs, including DAURISMO™ (Pfizer, 2018), TRIKAFTA® (Vertex Pharmaceuticals, 2019), VERZENIO® (Eli Lilly, 2017),SYMDEKO® (Vertex Pharmaceuticals, 2018), ORKAMBI® (Vertex Pharmaceuticals, 2015), and PREZISTA® (Johnson & Johnson, 2016) manufactured employing the continuous technique, have been approved by the FDA.

At the present time, numerous technology providers / equipment suppliers are involved in delivering the required technologies and equipment for continuous manufacturing; these involve continuous flow reactors (plug flow reactors, continuous stirred tank reactors (CSTR) and microreactors), continuous coaters, continuous granulators, continuous chromatography equipment, continuous mixers / blenders, continuous dryers and process analytical technologies (PAT). In addition to that, several companies have made heavy investments in order to install this technology and diversify their facilities and capabilities. Pioneers and innovators in this domain have received substantial support along the lines of grants from different administering institutes and incentives from leading regulatory agencies as well. It is also crucial to underline that, in spite of the continuing efforts, the adoption of this technology is facingmajor barriers, such asprocess development restrictions,cost of equipment, establishment of a new facility and maintenance of the equipment. Be that as it may, owing to the rising interest of investors and technological advancements, we are led to believe that the opportunity for technology developers and manufacturers / users engaged in this domain is anticipated to grow over the forthcoming future.

Market Dynamics

Market Drivers

Imperative for Enhanced Operational Efficiency Across Diverse Industries

Continuous manufacturing, with its persistent and incessant production processes, approaches the long-establishedquestionsrelated to the conventional  process of batch manufacturing. The elimination of downtime between production stages gives rise to a significantdecline in overall production time, allowing industries to meet market demands with unparalleledagility and speed.

The pharmaceutical domain, more particularly, is going through a radical shiftencouraged by the need for accelerated drug development and production. Continuous manufacturing's capability to align pharmaceutical processes has become a strategic asset, accelerating time-to-market for new drugs and ensuring a more adaptive approach to changing market dynamics. This efficacy gains significance as a critical driver, particularlywithing the bounds of the highly competitive and regulated pharmaceutical industry.

Along with that, the thrust for sustainability magnifies the callfor continuous manufacturing. Its innate skill to reduce waste and hone resource utilization streamlines with the worldwide emphasis on environmentally conscious practices. This not only improves corporate social responsibility but also acknowledges cost-effectiveness issues, making continuous manufacturing an attractive proposition for industries seeking both operational excellence and environmental administration. As industries progressivelydistinguish the imperative of efficiency and sustainability, the global continuous manufacturing market is worked up forrobust growth, accelerated by its revolutionary impact on production processes.

Market Restraints

With regard to numerous advantages of continuous manufacturing, the market faces several challenges due to the unique characteristics and requirements associated with them. Some of the key market challenges include:

• Initial Implementation Costs: The adoption of continuous manufacturing time and againcomprisessubstantial upfront investments in infrastructure and technology. Companies are likely toexperiencehindrances in utilizing this advanced approach owing to the notable initial implementation costs related to transitioning from conventional batch processes.
• Regulatory Challenges: The regulatory outlook for continuous manufacturing is yet in its developing phase, and organizationsare likely tofacedifficulties in navigating and complying to the regulatory needsparticular to this mode of manufacturing. Ensuring adherence with regulatory standards can be a hindrance, specifically for industries with stringent neglect, such as pharmaceuticals.

Market Opportunities

Potential to Significantly Reduce Production Lead Times and Enhance Overall Operational Dexterity

Since industries are essentially prioritizing responsiveness and efficiency to market demands, the concept of continuous manufacturing methodsurfaces as a strategic solution. The capability to impeccablyconsolidate production processes not only propels time-to-market for novel products but also expeditesswift adjustments to varying consumer preferences and market dynamics. In addition to that, the continuous manufacturing model streamlines well with the present focus on sustainability, as it mitigates waste and optimizes resource utilization. This opportunity is specifically promising for industries such as pharmaceuticals, where the demand for swifter drug development and production is crucial, making continuous manufacturing animpetus for game-changing and competitive benefits on a global scale.

Market Trends

• Increased Adoption in Pharmaceuticals: The global continuous manufacturing market is experiencing a notable trend of greater adoption within the pharmaceutical sphere. Since pharmaceutical firmsstrive for ways to speed up drug development and improve production efficacy, the continuous manufacturing methodsdemonstratesinstrumental in achieving these goals, accelerating a soaring trend across the industry.
• Integration of Advanced Technologies: A remarkable trend is the incorporation of innovative technologies, such as real-time monitoring and control systems, in continuous manufacturing processes. This unionimproves the preciseness and adaptability of continuous production, enabling industries to preservesuperior-quality standards and answerswiftly to modifications in production conditions. The continuing technological upgrades contribute to the development and refinement of continuous manufacturing methods, fostering a dynamic and innovative market outlook.

Continuous Manufacturing Market: Key Segments

By Product

• Integrated Systems
• Semi-continuous Systems
  • Continuous Granulators
  • Continuous Coaters
  • Continuous Blenders
  • Continuous Dryers
  • Continuous Compressors
  • Other Semi-continuous Systems (Milling Equipment and Weighing/Measurement Equipment)
• Controls/Software

By Application

• End Product Manufacturing
  • Solid Dosage
  • Liquid Dosage
• API Manufacturing

By End User

• R&D Departments
  • Research Institutes
  • Contract Research Organization (CROs)
• Full-scale Manufacturing Companies
  • Contract Manufacturing Organization (CMOs)
  • Pharmaceutical Companies

By Key Geographical Regions

• North America
• Europe
• Asia-Pacific
• Middle East and Africa
• South America

Continuous Manufacturing Market: Segmental Analysis

Based on product, the global continuous manufacturingmarket is divided into integrated systems, semi-continuous systems, and controls. The integrated systems dominated the product segment across the market, as it allows end-to-end manufacturing to convert raw materials into final products. Along with that, these systems save significant time and cost by integrating different pharmaceutical processes in a single system.

Based on application, the global continuous manufacturing market includes active pharmaceutical ingredient (API) manufacturing and end product manufacturing. The end product manufacturing is further categorized into solid dosage and liquid dosage. The end product manufacturing is dominating the application segment attributed to the easily available technology for end product manufacturing as compared to API manufacturing by continuous processes.

Based on end user, the global continuous manufacturing market includes R&D departments and full-scale manufacturing companies. The full-scale manufacturing companies further include CMOs and pharmaceutical companies. The full-scale manufacturing companies is holding the highest market share across the segment owing to the growing adoption of continuous technologies by pharmaceutical manufacturing companies and CMOs to address the challenges associated with product quality, drug supply and operational costs.

Continuous Manufacturing Market: Regional Analysis

North America is holding the largest share in the global continuous manufacturing marketdue to a combination of factors. The support from regulatory bodies, initiation by leading pharmaceutical companies, and the need for pharmaceutical manufacturers to mitigate increasing operational costs and eliminate issues associated with inconsistent quality of pharmaceutical products produced through batch manufacturing.

Figure 4. Continuous Manufacturing Market: Distribution by Region

Get more details on this report - Request Free Sample

Leading Continuous Manufacturing Developers

Industry Trends and Global Forecasts, 2023-2035 report features an extensive study of the current market landscape, market size and future opportunities associated with the Continuous Manufacturing market, during the given forecast period. Further, the market report highlights the efforts of several stakeholders engaged in this rapidly emerging segment of the biopharmaceutical industry. Key takeaways of the continuous manufacturing market are briefly discussed below. 

The report includes the list of players operating in the global Continuous Manufacturing market. Some of the key players include:

• Bosch Packaging Technology
• Baker Perkins Ltd.
• Coperion GmbH
• Glatt GmbH
• GEA Group AG
• KORSCH AG
• Munson Machinery Company Inc.
• Siemens
• Scott Equipment
• Thermo Fisher Scientific Inc.

Recent Developments in the Continuous Manufacturing Market

Several recent developments have taken place in the field of continuous manufacturing, some of which have been outlined below. These developments, even if they took place post the release of our market report, substantiate the overall market trends that we’ve outlined in our analysis chronologically.

• In April 2023, Arranta Bio (a Recipharm firm) entered into an agreement with MIT to develop a continuous manufacturing technology for mRNA therapeutics. 
• In April 2023, Exothera inked a deal with Quantoom Biosciences to gain access to Quantoom's Nfinity technology, a continuous production platform for RNA.
• In March 2023, Curia collaborated with Corning to expand and accelerate continuous-flow development and manufacturing programs for the chemical and biopharmaceutical industries globally. The collaboration marks the first global installation of Corning's G1 production system to support higher-quality API-chemical production using flow-chemistry technology.

Scope of the Report

The market report presents an in-depth analysis of the various firms / organizations that are engaged in this market, across different segments, as defined in the below table: